Summary: H.R.4832 — 107th Congress (2001-2002)All Information (Except Text)

There is one summary for H.R.4832. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (05/23/2002)

Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.